Evaluation of the efficacy of aminolevulinic acid-dependent photodynamic therapy on melanoma cancer cells treated with tocopherol succinate (in-vitro)

Homa Kouchesfahani; Kazem Parivar; Mohammad Nabiuni; Mohaddese Mohammadi-Sardoo

Zahedan Journal of Research in Medical Sciences

The Official Journal of Zahedan University of Medical Sciences

Current Issue All Issues In Press Articles Search Accepted Manuscripts

Journal Information Boards and Committees Indexing and Listing Sources Journal Metrics Publication Ethics and Malpractice Statement Reviewer and AE Registration Form Support Contact Us Open Peer Review (OPR)

APC

Authors Guide Submit Manuscript

Evaluation of the efficacy of aminolevulinic acid-dependent photodynamic therapy on melanoma cancer cells treated with tocopherol succinate (in-vitro)

Author(s):

Homa Kouchesfahani¹,

Kazem Parivar²,

Mohammad Nabiuni¹,

Mohaddese Mohammadi-Sardoo^3,*

1Assistant Professor of Biology, School of Science, Tarbiat Moallem University, Tehran, Iran.

2Professor of Biology, School of Science, Islamic Azad University, Tehran Science and Research Branch, Tehran, Iran.

3MSc of Biology, School of Science, Tarbiat Moallem University, Tehran, Iran.

Zahedan Journal of Research in Medical Sciences:Vol. 13, issue 8; e93752

Published online:May 26, 2011

Article type:Research Article

Received:Jul 20, 2010

Accepted:Oct 05, 2010

How to Cite:Kouchesfahani H, Parivar K, Nabiuni M, Mohammadi-Sardoo M. Evaluation of the efficacy of aminolevulinic acid-dependent photodynamic therapy on melanoma cancer cells treated with tocopherol succinate (in-vitro).Zahedan J Res Med Sci.2011;13(8):e93752.

Abstract

Background: Photodynamic therapy (PDT) using 5-aminolevulinic acid (ALA) to produce an intracellular photo-sensitizer, a protoporphyrin molecule IX (PPIX) which absorbs light and targets cells, is a promising cancer treatment. Unfortunately, treatment failures are still a common occurrence when ALA is used. In this study, in order to enhance the efficacy of ALA-dependent photodynamic therapy, the effects of photodynamic therapy on melanoma cancer cells were studied after treating them with tocopherol succinate.

Materials and Methods: In this experimental study melanoma cells were cultured in RPMI 1640 medium for 24 h. then, cells were treated with tocopherol succinate (6μm/ml). After 48 and 72 hours, the mediums were replaced by serum-free medium in the darkness, with ALA, 0.1mg/ml and then cells incubated for 4h. After that, cells were irradiated by using Nd: YAG laser (532 nm). After 24h, cell survival was measured by the MTT assay.

Results: Twenty-four hours after PDT, among compared groups, pretreated cells with tocopherol succinate showed significant lower cell viability than control group.

Conclusion: Induction of differentiation by using tocopherol succinate augmented intracellular PPIX accumulation in cells treated with ALA. Therefore phototoxic cell death after exposure to 532nm light enhances significantly in tocopherol succinate-pretreated cells. This study suggests that tocopherol succinate may act as a biological enhancer of ALA based photodynamic therapy.

Keywords

Fulltext

The full text of this article is available on the PDF file.

References

1.
The References of this article are available on the PDF file.

Import into EndNote Import into BibTex

Share on

Comments

Number of Comments:0

Metrics

Purchasing Reprints

Copyright Clearance Center (CCC) handles bulk orders for article reprints for Brieflands. To place an order for reprints, please click here ( https://www.copyright.com/landing/reprintsinquiryform/ ). Clicking this link will bring you to a CCC request form where you can provide the details of your order. Once complete, please click the ‘Submit Request’ button and CCC’s Reprints Services team will generate a quote for your review.

Search Relations

Author(s):

Homa Kouchesfahani:[PubMed][Scholar]
Kazem Parivar:[PubMed][Scholar]
Mohammad Nabiuni:[PubMed][Scholar]
Mohaddese Mohammadi-Sardoo:[PubMed][Scholar]